Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Join SI Premium – FREE
Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- UBS Starts Jiangsu Etern (600105:CH) at Buy
- Culp, Inc. (CULP) Misses Q4 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
